<!DOCTYPE html><html prefix="og: http://ogp.me/ns#" lang="zh">
<!-- Mirrored from cn.nytimes.com/business/20130722/c22drugs/zh-hant/dual/ by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:16:48 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head><meta charset="UTF-8"><!-- Browser render  --><meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"><meta name="renderer" content="webkit"><!-- End Browser render --><meta name="keywords" content=""><meta name="description" content="英國製藥企業葛蘭素史克涉嫌通過上海臨江旅行社行賄，被中國政府調查。有線索表明，臨江旅行社還與多家國際製藥商有業務往來。"><meta id="uuid" name="uuid" content="1b519e4cf96068d0a21d234486a734a8"><meta id="headline" name="headline" content="葛蘭素史克行賄案可能牽涉更多製藥企業 - 紐約時報中文網"><meta id="byline" name="byline" content="DAVID BARBOZA"><meta id="date" name="date" content="2013-07-22T11:12:25.000Z"><link rel="alternate" href="../../index.html" hreflang="zh-Hans"><link rel="alternate" href="../index.html" hreflang="zh-Hant"><link rel="canonical" href="../index.html"><link rel="alternate" type="application/rss+xml" href="https://cn.nytimes.com/rss/zh-hant/"><meta name="apple-itunes-app" content="app-id=807498298, app-argument=nytimescn://article:1b519e4cf96068d0a21d234486a734a8"><meta name="lang" property="lang" content="zh-cmn-hant"><!-- Apple IOS safari private meta --><link rel="apple-touch-icon-precomposed" sizes="144×144" href="../../../../../../static01.nyt.com/images/icons/ios-ipad-144x144.png"><link rel="apple-touch-icon-precomposed" sizes="114×114" href="../../../../../../static01.nyt.com/images/icons/ios-iphone-114x144.png"><link rel="apple-touch-icon-precomposed" href="../../../../../../static01.nyt.com/images/icons/ios-default-homescreen-57x57.png"><meta name="apple-mobile-web-app-title" content="葛蘭素史克行賄案可能牽涉更多製藥企業 - 紐約時報中文網"><meta name="apple-mobile-web-app-capable" content="yes"><!-- End Apple IOS safari private meta --><!-- Viewport and mobile --><meta name="viewport" content="width=device-width,initial-scale=1,user-scalable=no,maximum-scale=1,minimum-scale=1,minimal-ui"><!-- End viewport and mobile --><meta http-equiv="Cache-Control" content="no-siteapp"><meta name="format-detection" content="telephone=no"><meta name="HandheldFriendly" content="true"><meta name="MobileOptimized" content="320"><meta name="x5-orientation" content="portrait"><meta name="full-screen" content="yes"><meta name="x5-fullscreen" content="true"><meta name="browsermode" content="application"><meta name="x5-page-mode" content="app"><meta name="msapplication-tap-highlight" content="no"><meta property="og:title" content="葛蘭素史克行賄案可能牽涉更多製藥企業"><meta property="og:type" content="article"><meta property="og:url" content="../index.html"><meta property="og:description" content="英國製藥企業葛蘭素史克涉嫌通過上海臨江旅行社行賄，被中國政府調查。有線索表明，臨江旅行社還與多家國際製藥商有業務往來。"><meta property="og:site_name" content="紐約時報中文網"><meta property="article:publisher" content="https://www.facebook.com/nytimeschinese"><meta property="article:published_time" content="2013-07-22T11:12:25.000Z"><meta property="fb:pages" content="1504603339831430"><meta property="fb:app_id" content="853699254762608"><meta property="og:image" content="../../../../../../static01.nyt.com/images/2013/07/22/business/drug/drug-articleLarge.html"><meta property="twitter:card" content="summary_large_image"><meta property="twitter:url" content="../index.html"><meta property="twitter:title" content="葛蘭素史克行賄案可能牽涉更多製藥企業"><meta property="twitter:description" content="英國製藥企業葛蘭素史克涉嫌通過上海臨江旅行社行賄，被中國政府調查。有線索表明，臨江旅行社還與多家國際製藥商有業務往來。"><meta property="twitter:domain" content="cn.nytimes.com"><meta property="twitter:site" content="@nytchinese"><meta property="twitter:creator" content="@nytchinese"><meta property="twitter:image:src" content="../../../../../../static01.nyt.com/images/2013/07/22/business/drug/drug-articleLarge.html"><meta name="PT" content="article"><meta name="PST" content="News"><meta name="CG" content="business"><meta name="SCG" content=""><meta name="sourceApp" content="nyt-china-web"><meta name="ptime" content="20130722050515"><meta name="utime" content="20130722111225"><meta name="pdate" content="20130722"><meta name="dat" content="Jul. 22, 2013"><meta name="hdl" content="葛蘭素史克行賄案可能牽涉更多製藥企業"><meta name="byl" content="DAVID BARBOZA"><meta name="lp" content="英國製藥企業葛蘭素史克涉嫌通過上海臨江旅行社行賄，被中國政府調查。有線索表明，臨江旅行社還與多家國際製藥商有業務往來。"><link rel="shortcut icon" href="https://static01.nyt.com/favicon.ico"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/style-flex.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/web/style.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/nytcn_core/article.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/slideshow/slideshow.min619b.css?v=f1810d8"><link rel="stylesheet" href="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/css/cookie-banner/style.min619b.css?v=f1810d8"><title>葛蘭素史克行賄案可能牽涉更多製藥企業 - 紐約時報中文網</title></head><script>var js_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/js";
 var imgs_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style/imgs";
 var style_static_path = "https://d1f1eryiqyjs0r.cloudfront.net/style";
 var site = 1;
 var sectionName = "business";
 var adTyp = "art";
 var cookieString = {
     "title": "您的追蹤器設置",
     "headline": "我們使用 cookie 做什麼？",
     "summary": '<p>我們利用cookies和類似的技術識別您的重複訪問和偏好。我們還使用它們來衡量廣告系列的效果，定位廣告並分析和網站流量。更多關於cookies的資訊（包括如何停用），<a href="https://www.nytimes.com/zh-hant/privacy/cookie-policy" rel="noreferrer noopener" target="_blank" data-testid="GDPR-policy">請查看我們的「Cookie政策」</a>。</span><span>自2020年7月20日起，我們將根據您在我們服務中所訪問的內容類型向您顯示我們認為與您的興趣相關的廣告。您可以<a href="https://www.nytimes.com/zh-hant/privacy/cookie-policy#how-do-i-manage-trackers" rel="noreferrer noopener" target="_blank" data-testid="GDPR-objection">提出反對</a>。希望了解更多信息，請參見我們的<a href="https://nytimes.com/zh-hant/privacy/privacy-policy#we-allow-for-personalized-advertising-on-times-services" rel="noreferrer noopener" target="_blank" data-testid="GDPR-privacy">隱私政策</a>。</p><p>透過在此處點擊「我接受」或者「X」， 您將被視為同意使用cookies。您隨時可以通過我們的Cookie政策來更改您的跟踪器偏好。</p>',
     "button": "接受",
     "trackerButton": "您的追蹤器設置",
     "rejectButton": "拒絕所有",
     "lang": 'zh-hant',
     "trackerLink": "https://www.nytimes.com/zh-hant/privacy/cookie-policy",
 };
 var purrString = {
     "button": "請勿出售我的個人資訊",
     "snackbar": "你的設定已經保存在此瀏覽器和設備上。如果你清除了 cookie，這些設定也會被清除。",
     "snackbarError": "Something went wrong",
     "optedOutText": "我们不再出售您的個人資訊",
     "CFALinkText": "California Notices",
     "purrPopupTitle": "Your request to not sell your data will be stored for this browser and device",
     "purrPopupSummary": "If you clear your cookies, your preference will be forgotten. As a California resident, you have additional rights under the California Consumer Privacy Act of 2018. While The New York Times Company does not “sell” personal information of its readers as the term “sell” is traditionally understood, “sell” under the CCPA is broadly defined. To learn more, review the text below.",
     "purrPopupButton": "DISMISS",
     "purrPopupScrollContent": 'ssa sed. Nec sagittis aliquam malesuada bibendum arcu. Nunc sed blandit libero volutpat sed cras ornare arcu. Metus vulputate eu scelerisque felis imperdiet proin. Elit eget gravida cum sociis natoque penatibus. Sodales ut eu sem integer. Vitae auctor eu augue ut lectus arcu bibendum at. Vulputate ut pharetra sit amet aliquam id diam. Eu tincidunt tortor aliquam nulla facilisi cras fermentum odio eu. Imperdiet dui accumsan sit amet nulla facilisi morbi. Laoreet non curabitur gravida arcu ac tortor dignissim. Magna fringilla urna porttitor rhoncus dolor purus. In nulla posuere sollicitudin aliquam. At elementum eu facilisis sed odio. Diam in arcu cursus euismod quis viverra. Viverra suspendisse potenti nullam ac tortor vitae purus. Felis donec et odio pellentesque diam volutpat. Lacus sed turpis tincidunt id aliquet risus feugiat in.Aliquam ut porttitor leo a diam sollicitudin tempor',
     "lang": 'zh-hant'
 };
 cbSectionName = "business";
 cbByline = "DAVID BARBOZA";</script><!-- Google Tag Manager --><script>(function(w,d,s,l,i){
     w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});
     var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';
     j.async=true;j.src='../../../../../../www.googletagmanager.com/gtm5445.html?id='+i+dl;
     f.parentNode.insertBefore(j,f);
 })(window,document,'script','dataLayer','GTM-KTDZV8V');</script><!-- End Google Tag Manager --><!-- chartbeat --><script type="text/javascript">var _sf_startpt=(new Date()).getTime()</script><!-- /chartbeat --><body class="news"><main class="container-fluid main clearfix"><header class="row title-bar"><div class="nav-button default" id="menuBtn"><i class="icon-bars"></i></div><h1 class="logo"><a href="/"><svg role="img" aria-label="" width="90%" height="90%"><image width="100%" height="100%" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="/d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hant.svg" src="../../../../../../d1f1eryiqyjs0r.cloudfront.net/style/imgs/mweb/nytimes-zh-hant%402x.png" alt="" border="0"></image></svg></a></h1><div class="nav-button default" id="gearBtn"><i class="icon-gear"></i></div><div class="popup gear-popup"><div class="tips-container"><div class="tips-border"></div><div class="tips-inner"></div></div><div class="popup-container"><div class="popup-body"><div class="setting-title">簡繁中文</div><div class="setting-option"><a href="../../index024e.html?changeLang=zh-hans">簡體 </a><a href="../../index27d8.html?changeLang=zh-hant" class="active">繁體</a></div><div class="setting-title">紐約時報 出版語言</div><ul class="menu-list"><li><a href="https://www.nytimes.com/">ENGLISH (英語)</a></li><li><a href="https://www.nytimes.com/es/">ESPAÑOL (西班牙語)</a></li></ul><div class="setting-title">字體大小</div><div class="setting-option"><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="small"> 小</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="normal" checked="checked"> 中</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="large"> 大</label></div><div class="form-check form-check-inline"><label class="form-check-label"><input class="form-check-input font-size" type="radio" name="changeFontSizeRadio" value="xlarge"> 超大</label></div></div></div></div></div></header><div class="top_banner_ad" id="topad" data-target="{&quot;pos&quot;:&quot;top&quot;,&quot;adv&quot;:&quot;&quot;}"></div><div class="article-area"><div class="setting-bar row"><div class="col-4 section-title"><h3>商業與經濟</h3></div><div class="col-8 setting-btns"><div class="row"><div class="col-6"><ul class="dual-btn"><li><a href="../../index.html"><span class="setting-btn-text">中文</span> <span class="setting-btn-text-mobile">中</span></a></li><li><a href="javascript:;" class="active"><span class="setting-btn-text">中英雙語</span> <span class="setting-btn-text-mobile">雙語</span></a></li><li><a href="#" target="_blank"><span class="setting-btn-text">英文 <i class="icon-share-square"></i> </span><span class="setting-btn-text-mobile">英</span></a></li></ul></div><div class="col-6 share-tools-top-container"><ul class="share-tools mobile-article"><li><a href="http://v.t.sina.com.cn/share/share.php?&amp;title=%E8%91%9B%E8%98%AD%E7%B4%A0%E5%8F%B2%E5%85%8B%E8%A1%8C%E8%B3%84%E6%A1%88%E5%8F%AF%E8%83%BD%E7%89%BD%E6%B6%89%E6%9B%B4%E5%A4%9A%E8%A3%BD%E8%97%A5%E4%BC%81%E6%A5%AD&amp;url=https://cn.nytimes.com/business/20130722/c22drugs/zh-hant/" target="_blank"><i class="icon-weibo"></i></a></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20130722/c22drugs/zh-hant/" data-headline="%E8%91%9B%E8%98%AD%E7%B4%A0%E5%8F%B2%E5%85%8B%E8%A1%8C%E8%B3%84%E6%A1%88%E5%8F%AF%E8%83%BD%E7%89%BD%E6%B6%89%E6%9B%B4%E5%A4%9A%E8%A3%BD%E8%97%A5%E4%BC%81%E6%A5%AD"> --><!-- <i class="icon-wechat"></i> --><!-- </a> --><!-- </li> --><li><a href="https://www.facebook.com/sharer/sharer.php?u=https://cn.nytimes.com/business/20130722/c22drugs/zh-hant/" trage="_blank"><i class="icon-facebook"></i></a></li><li><a href="https://plus.google.com/share?url=https://cn.nytimes.com/business/20130722/c22drugs/zh-hant/" target="_blank"><i class="icon-google"></i></a></li><li><a href="https://twitter.com/share?text=%E8%91%9B%E8%98%AD%E7%B4%A0%E5%8F%B2%E5%85%8B%E8%A1%8C%E8%B3%84%E6%A1%88%E5%8F%AF%E8%83%BD%E7%89%BD%E6%B6%89%E6%9B%B4%E5%A4%9A%E8%A3%BD%E8%97%A5%E4%BC%81%E6%A5%AD&amp;url=https://cn.nytimes.com/business/20130722/c22drugs/zh-hant/" target="_blank"><i class="icon-twitter"></i></a></li><li><div class="line-it-button" data-lang="zh_Hant" data-type="share-g" data-url="https://cn.nytimes.com/business/20130722/c22drugs/zh-hant/" style="display: none;"></div><script src="../../../../../../d.line-scdn.net/r/web/social-plugin/js/thirdparty/loader.min.js" async="async" defer="defer"></script></li><!-- <li> --><!-- <a href="javascript:void(0);" class="JS_shareForQrcode" data-url="https://cn.nytimes.com/business/20130722/c22drugs/zh-hant/" data-headline="%E8%91%9B%E8%98%AD%E7%B4%A0%E5%8F%B2%E5%85%8B%E8%A1%8C%E8%B3%84%E6%A1%88%E5%8F%AF%E8%83%BD%E7%89%BD%E6%B6%89%E6%9B%B4%E5%A4%9A%E8%A3%BD%E8%97%A5%E4%BC%81%E6%A5%AD"> --><!-- <i class="icon-qrcode"></i> --><!-- </a> --><!-- </li> --></ul><div class="share-btn"><i class="icon-forward"></i></div></div></div></div></div><article class="article-content article-dual font-normal"><div class="article-header"><header><small></small><h1>葛蘭素史克行賄案可能牽涉更多製藥企業</h1><h1 class="en-title">Files Suggest a Graft Case in China May Expand</h1></header><div class="byline-row"><div class="byline-box"><div class="byline"><address>DAVID BARBOZA</address><time pudate="2013-07-22 11:12:25" datetime="2013-07-22 11:12:25">2013年7月22日</time></div><div class="share-btn"><i class="icon-forward"></i></div></div></div></div><div class="row"><section class="article-body"><div class="article-partial"><div class="article-body-item col-lg-5"><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">SHANGHAI — A few weeks ago, when Chinese investigators raided a small travel agency in this fast-growing city, they came upon something startling.</div></div><div class="col-lg-6"><div class="article-paragraph">上海——幾周前，中國調查員突襲了這個快速發展的城市當中的一家小旅行社，發現了一些令人吃驚的東西。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The agency appeared to be using fake contracts and travel invoices to help executives at the British pharmaceutical giant GlaxoSmithKline bribe doctors, hospitals, foundations and government officials, Chinese authorities said.</div></div><div class="col-lg-6"><div class="article-paragraph">\r中國官員稱，這家旅行社似乎使用了假合同和旅遊發票來協助英國製藥巨頭葛蘭素史克公司（GlaxoSmithKline，簡稱GSK）賄賂醫生、醫院、基金會和政府官員。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Soon after, the police shut Shanghai Linjiang International Travel Agency and detained its boss, Weng Jianyong. Four Chinese-born Glaxo executives were also held on suspicions of bribery and tax fraud.</div></div><div class="col-lg-6"><div class="article-paragraph">\r不久之後，警方關閉了上海臨江國際旅行社，並拘留了其負責人翁劍雍。四名中國出生的GSK高管也因為賄賂和稅務欺詐嫌疑而被拘留。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">But documents obtained by The New York Times show that in the last three years at least six other global pharmaceutical companies, including Merck, Novartis, Roche and Sanofi, used the same travel agency to make arrangements for events and conferences.</div></div><div class="col-lg-6"><div class="article-paragraph">\r然而，《紐約時報》獲得的文件顯示，在過去三年里，使用同一家旅行社安排了活動和會議至少還有另外六家全球性製藥公司，包括默克(Merck)、諾華(Novartis)、羅氏(Roche)和賽諾菲(Sanofi)。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The records included invoices for hotel bookings, travel visas and airline tickets to Chinese cities, and to Australia, Italy, Japan, Korea and the United States. One of the drug companies appears to have used the travel agency to make a $2,500 grant to the Cancer Foundation of China.</div></div><div class="col-lg-6"><div class="article-paragraph">\r這些記錄包括酒店預訂發票、旅行簽證和飛往中國各個城市的機票，還有飛往澳大利亞、意大利、日本、韓國和美國的機票。其中一家製藥公司似乎通過該旅行社向中國癌症基金會捐贈了2500美元（約合15347元人民幣）。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The documents contain no indication of wrongdoing. But they suggest that big drug makers other than Glaxo could come under scrutiny as the Chinese government widens its investigation into fraud and corruption in the nation’s fast-growing market for pharmaceutical products. Chinese authorities did not respond to requests for interviews.</div></div><div class="col-lg-6"><div class="article-paragraph">\r這些文件並沒有顯示任何不當行為，但卻說明GSK以外的一些大型製藥公司可能也會受到審查，因為中國政府擴大了對該國快速增長的醫藥產品市場的欺詐和腐敗調查。中國當局沒有回應記者的採訪請求。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Over the weekend, Merck and Roche acknowledged using Shanghai Linjiang International Travel Agency. But they gave few other details about the nature of the relationship.</div></div><div class="col-lg-6"><div class="article-paragraph">\r周末，默克和羅氏承認使用過上海臨江國際旅行社。但他們沒有提供多少關於這層關係性質的其他細節。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">A spokeswoman in China for Merck would say only that the American company stopped using the travel agency in 2011, when Merck introduced a new procurement system.</div></div><div class="col-lg-6"><div class="article-paragraph">\r默克公司在中國的一名女發言人只願意透露，這家美國公司在2011年斷絕了與該旅行社的往來，當時默克公司引入了一個新的採購系統。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Roche said it had worked with various agencies in China for business travel or organizing events, including Shanghai Linjiang International Travel Agency.</div></div><div class="col-lg-6"><div class="article-paragraph">\r羅氏公司表示，它曾與中國多家旅行社在商務旅行或組織活動方面進行合作，其中包括上海臨江國際旅行社。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“Once allegations of illegal behavior by this agency on behalf of other parties were made public, we made an internal decision to immediately stop working with this agency, and we have begun to review the documentation of our previous interactions with them,” Roche said in a statement on Saturday. “This review is currently ongoing.”</div></div><div class="col-lg-6"><div class="article-paragraph">\r「這家旅行社因代表他方的非法行為受到指控的事實公開之後，我們做了一個內部決定，立刻停止與這家旅行社的合作，而且我們也已經開始審查我們與他們先前往來的文件，」羅氏在周六的一份聲明中稱。「審查目前正在進行。」</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">A spokesman for Novartis said by e-mail that the company could not confirm or deny whether it had used the agency. Sanofi did not respond to repeated requests for an interview.</div></div><div class="col-lg-6"><div class="article-paragraph">\r諾華公司的發言人在電子郵件中表示，該公司無法確認或否認它是否曾使用該機構。賽諾菲公司沒有回應多次的採訪請求。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The scandal has battered the reputation of GlaxoSmithKline, which is also known as GSK. At a news conference last week, investigators likened the British drug maker to a boss in a criminal organization. They said it used the travel agency to bribe officials in hopes of illegally increasing drug sales and raising the prices of its products in China.</div></div><div class="col-lg-6"><div class="article-paragraph">\r這一醜聞重創了GSK的聲譽。在上周的一次新聞發佈會上，調查人員把這家英國製藥商比作犯罪集團的老闆。他們說，該公司通過旅行社賄賂官員，目的是非法提高藥品銷量，並提高其產品在中國的價格。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">GlaxoSmithKline has said that what the government says its staff engaged in was “shameful,” and at odds with its policies. It pledged to cooperate with investigators. Over the weekend, the company’s chief executive, Andrew Witty, who is based in London, dispatched three top executives to China to deal with the scandal. On Sunday, one of the Glaxo executives met with investigators and apologized, according to Xinhua, the state-run news agency.</div></div><div class="col-lg-6"><div class="article-paragraph">\rGSK稱，中國政府指控其員工參與的行為是「可恥的」，與公司政策不符。它承諾將配合調查人員的工作。上周末，常駐倫敦的該公司首席執行官安德魯·威蒂(Andrew Witty)派出三名高管到中國處理該醜聞。據官方新聞機構新華社報道，周日，前述GSK高管之一會晤了調查人員並進行了道歉。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Meanwhile, the company’s China finance chief, Steve Nechelput, a British national, has been barred by Chinese authorities from leaving the country, though a person familiar with his case says he is not a target of the investigation.</div></div><div class="col-lg-6"><div class="article-paragraph">\r同時，該公司<span>駐華財務副總裁</span>、英國人史蒂夫·尼克爾普特(Steve Nechelput)已經被中國當局禁止離境，不過，一名了解他處境的人士稱他並不是這次調查的目標。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">According to the authorities, Glaxo has used 700 travel and consulting firms and spent nearly $500 million on conferences since 2007. Some travel agencies helped Glaxo executives commit fraud, the government asserts. But investigators have named just one: Shanghai Linjiang International Travel Agency.</div></div><div class="col-lg-6"><div class="article-paragraph">\r官方稱，自2007年以來，GSK使用過700家旅行社和諮詢公司，在會議上支出了近5億美元。政府斷言，一些旅行社協助GSK高管進行欺詐。不過，調查人員只點出了其中一家的名字：上海臨江國際旅行社。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The government said the Linjiang agency did very little booking on its own and mostly acted as a “money platform” that allowed Glaxo to create a huge slush fund. </div></div><div class="col-lg-6"><div class="article-paragraph">\r政府稱，臨江旅行社很少自行預定，主要是充當「洗錢平台」，使得GSK可以設立數額巨大的賄賂基金。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">According to the government, the travel agency was handling about $16 million worth of Glaxo business a year, but seemed to be doing very little work. The government also said Mr. Weng had said that several other foreign drug companies were also “involved” in such actions, though he did not elaborate.</div></div><div class="col-lg-6"><div class="article-paragraph">\r政府稱，該旅行社每年處理GSK約1600萬美元的業務，但是似乎並沒有做多少工作。政府還說，翁劍雍供認其他幾家外國葯企也「涉及」這種行為，但他沒有給出詳細說明。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Corporate fraud specialists say using travel agencies, and marketing or consulting firms, to launder money, embezzle or create slush funds to bribe officials is common in China, even at multinational corporations operating in the country.</div></div><div class="col-lg-6"><div class="article-paragraph">\r企業詐騙行為研究專家稱，利用旅行社、營銷機構或諮詢公司洗錢、挪用公款或設立用於賄賂官員的基金的做法在中國很常見，甚至那些跨國公司的中國分公司也是如此。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“People don’t realize there’s an active market for fake receipts and that shell companies are used to make bribe payments,” said Violet Ho, head of greater China operations at Kroll Advisory Solutions.</div></div><div class="col-lg-6"><div class="article-paragraph">\r德安華(Kroll Advisory Solutions)大中華區負責人何越(Violet Ho)稱，「人們沒有意識到，中國存在一個活躍的假髮票市場，企業紛紛通過皮包公司來行賄。」</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">On Thursday, a handful of employees could be seen at the office of Shanghai Linjiang International Travel Agency in a modest building in Shanghai, but they declined to talk to visitors. Neighbors said they noticed the Linjiang staff was busy shredding documents, some of which could be seen piling up in hallway trash bags.</div></div><div class="col-lg-6"><div class="article-paragraph">\r周四，在一棟不起眼的建築里，上海臨江國際旅行社的一些員工在工作，但是他們拒絕與來訪者說話。隔壁公司的人說，他們注意到，臨江旅行社的員工忙於銷毀文件，其中一些文件裝進了垃圾袋，堆在走廊里。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">Reached by telephone Saturday, one Linjiang manager said: “Our main business was organizing conferences. Everything we did was standard practice.” He declined to say much more.</div></div><div class="col-lg-6"><div class="article-paragraph">\r周六，該旅行社的一名經理在接聽電話時說，「我們的主要業務是組織會議。我們做的一切都是符合標準的。」他拒絕多說。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">How the small agency secured business with many of the world’s biggest drug makers remains a mystery.</div></div><div class="col-lg-6"><div class="article-paragraph">\r目前尚不清楚，這樣一個小旅行社通過何種方式取得了眾多全球葯業巨頭的業務。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">According to corporate records, the agency was formed in 2006 by Shanghai Linjiang Holdings, a local property company, the former Chinese soccer star Wu Chenying and the family of the company’s current manager, Mr. Weng. In a telephone interview on Sunday, Tan Yidao, the chairman of Shanghai Linjiang Holdings, said he sold his stake and surrendered control to Mr. Weng and his wife six years ago, after trouble occurred when some tourists died while traveling to Thailand with the agency.</div></div><div class="col-lg-6"><div class="article-paragraph">\r公司記錄顯示，2006年，當地地產公司上海臨江控股，前足球明星吳承瑛，以及旅行社現任總經理翁劍雍的家人共同創立了這家旅行社。在周日的一次電話採訪中，臨江控股董事長談意道稱，六年前，在一些旅客隨該旅行社赴泰國旅行遇難之後，他賣掉了自己的股份，把管理權讓給了翁劍雍夫婦。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“I sold because I didn’t think the travel business would do well,” Mr. Tan said.</div></div><div class="col-lg-6"><div class="article-paragraph">\r他說，「我賣掉了股份，因為我覺得旅行業不好做。」</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">He said he did not know that Mr. Weng or his wife had contacts in the pharmaceutical business. Mr. Weng, he said, had been in the restaurant business and his wife had worked at a travel agency before forming Linjiang Travel. According to the Chinese government, Linjiang’s  business with Glaxo took off in about 2010. Rather than organize tours, the government said, the travel agency created fake invoices for Glaxo, and that helped touch off an investigation. Records reviewed by The Times include invoices listing payments to other travel agencies to book hotels and flights, suggesting that Linjiang acted as a liaison in the deals. Some large Chinese pharmaceutical companies and other multinationals were also listed in the records.</div></div><div class="col-lg-6"><div class="article-paragraph">\r他說，他不知道翁劍雍或翁劍雍的妻子與製藥業有聯繫。他說，翁劍雍原先是做餐館生意的，翁劍雍的妻子在旅行社成立前曾在另一家旅行社工作。中國政府稱，臨江旅行社與GSK之間的生意在2010年前後開始迅速發展。政府稱，旅行社沒有為GSK組織旅行，而是為該公司開具假髮票，由此引發了調查。《紐約時報》查核的記錄包括一些發票，其中列出了一些支付給其他旅行社訂酒店及航班的支出，這說明臨江旅行社在這些交易中起到了紐帶作用。中國的一些大葯企和其他一些跨國葯企也出現在了記錄上。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">The government says Mr. Weng and the GSK executives have confessed to faking invoices and bribing doctors and officials. </div></div><div class="col-lg-6"><div class="article-paragraph">\r政府說，翁劍雍及GSK高管已經承認發票造假及向醫生和官員行賄。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">In an interview seen last week on China Central Television, the big state-run broadcaster, Mr. Weng said he schemed with a senior GSK executive named Liang Hong, who is among the four who have been detained.</div></div><div class="col-lg-6"><div class="article-paragraph">\r上周，翁劍雍在接受大型官方電視網央視採訪時稱，他與GSK高管梁宏合謀。梁洪是被捕的四名GSK高管之一。</div></div></div><div class="row article-dual-body-item"><div class="col-lg-6"><div class="article-paragraph">“Liang would tell me he is going to visit some experts, or some government officials and he needs to send some gifts,” Mr. Weng said in the interview. “Gifts approved by the company are about $15 to $30. That won’t be enough. Liang would say, ‘Mr. Weng, please arrange some cash for me.’ That’s basically how it was done.”</div></div><div class="col-lg-6"><div class="article-paragraph">\r翁劍雍在採訪中說，「梁洪告訴我，他要去拜訪一些專家或政府官員，需要送禮。公司允許贈送的禮物價值在15美元到30美元之間。這不夠。梁洪會說，『翁先生，請幫我弄點兒現金。』基本上就是這麼辦的。」</div></div></div></div><div class="article-body-aside col-lg-3"></div></div></section></div><div class="col-lg-12 row author-info-container"><footer class="author-info"><p>Lynn Zhang及Yiyi Dong對本文有研究貢獻。</p><p>翻譯：林蒙克、梁英</p></footer></div></article><div class="container article-footer"><div class="row"><div class="col-lg-12 dual-refer-cont"><div class="related-cont"><h4>相關報導</h4><ul class="refer-list"><li class="article-refer"><div class="refer-list-item"><a href="../../../../20130718/c18glaxo/zh-hant/index.html" title="中國限制葛蘭素史克英籍高管離境"><div><h3 class="refer-list-headline">中國限制葛蘭素史克英籍高管離境</h3><p class="refer-pubdate">2013年7月18日</p></div></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="#https://cn.nytimes.com/china/20130717/c17drug/zh-hant/" title="讓國際葯企又愛又怕的中國市場"><div><h3 class="refer-list-headline">讓國際葯企又愛又怕的中國市場</h3><p class="refer-pubdate">2013年7月17日</p></div></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../../20130716/c16gsk/zh-hant/index.html" title="中國指葛蘭素史克通過旅行社行賄"><div><h3 class="refer-list-headline">中國指葛蘭素史克通過旅行社行賄</h3><p class="refer-pubdate">2013年7月16日</p></div><img alt="中國指葛蘭素史克通過旅行社行賄" src="../../../../../../static01.nyt.com/images/2013/07/16/business/global/16drug/16drug-thumbLarge-v2.html" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../../20130712/c12bribe/zh-hant/index.html" title="葛蘭素史克被控高管在華行賄"><div><h3 class="refer-list-headline">葛蘭素史克被控高管在華行賄</h3><p class="refer-pubdate">2013年7月12日</p></div><img alt="葛蘭素史克被控高管在華行賄" src="../../../../../../static01.nyt.com/images/2013/07/12/business/global/12iht-bribe/12iht-bribe-thumbLarge.html" width="75" height="75"></a></div></li><li class="article-refer"><div class="refer-list-item"><a href="../../../../20120703/c03glaxo/zh-hant/index.html" title="葛蘭素史克認繳30億美元罰款"><div><h3 class="refer-list-headline">葛蘭素史克認繳30億美元罰款</h3><p class="refer-pubdate">2012年7月3日</p></div></a></div></li></ul></div></div><div class="col-lg-12"><div class="related hot_article"><h5 class="related-title">最受歡迎</h5><ol class="related-articles"><li><a href="#https://cn.nytimes.com/usa/20220127/computer-chip-shortage-taiwan/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>戰棋推演報告稱台灣半導體工廠停產可能引發中美衝突</h4><img alt="戰棋推演報告稱台灣半導體工廠停產可能引發中美衝突" src="../../../../../../static01.nyt.com/images/2022/01/26/us/politics/26dc-wargames/merlin_177315390_5fcf8532-e370-4f81-8f99-45c6c83044f4-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220127/pakistan-united-states-china/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>「巴鐵」軍方為什麼想與中國保持距離？</h4><img alt="「巴鐵」軍方為什麼想與中國保持距離？" src="../../../../../../static01.nyt.com/images/2022/01/24/opinion/21Rafiq1/21Rafiq1-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220126/china-covid-19/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>中國追求「清零」將把國家置於災難之中</h4><img alt="中國追求「清零」將把國家置於災難之中" src="../../../../../../static01.nyt.com/images/2022/01/25/opinion/25emanuel/25emanuel-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/sports/20220127/peng-shuai-china-australian-open/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>澳網再現「彭帥在哪裡」：球員和觀賽者拒絕遺忘、為其發聲</h4><img alt="澳網再現「彭帥在哪裡」：球員和觀賽者拒絕遺忘、為其發聲" src="../../../../../../static01.nyt.com/images/2022/01/26/sports/26aus-china1/merlin_199503951_9c695f25-2b8e-41b4-9c97-bf91de7aa190-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/usa/20220125/gang-chen-mit-china/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>「我們在殘害我們自己」：華裔教授陳剛案背後的憤怒與幻滅</h4><img alt="「我們在殘害我們自己」：華裔教授陳剛案背後的憤怒與幻滅" src="../../../../../../static01.nyt.com/images/2022/01/24/science/24CHEN-promo/24CHEN-promo-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/opinion/20220127/virtual-reality-simulation/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>你可以開始相信，我們有可能會活在虛擬現實裡</h4><img alt="你可以開始相信，我們有可能會活在虛擬現實裡" src="../../../../../../static01.nyt.com/images/2022/01/26/opinion/26manjoo-image/26manjoo-image-thumbLarge.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220124/winter-olympics-china-beijing-xi-jinping/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>不再取悅世界：一屆展現習近平全面願景的冬奧會</h4><img alt="不再取悅世界：一屆展現習近平全面願景的冬奧會" src="../../../../../../static01.nyt.com/images/2022/01/13/world/00xi-olympics-30/00xi-olympics-30-thumbLarge.jpg"></article></a></li><li><a href="../../../../20220126/imf-world-economic-report/zh-hant/indexf61c.html?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>國際貨幣基金組織稱中美經濟放緩將拖累全球經濟</h4><img alt="國際貨幣基金組織稱中美經濟放緩將拖累全球經濟" src="../../../../../../static01.nyt.com/images/2022/01/25/multimedia/25global-econ-brf/25global-econ-brf-thumbLarge-v2.jpg"></article></a></li><li><a href="#https://cn.nytimes.com/asia-pacific/20220126/north-korea-launches-missiles-kim/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>朝鮮突然頻繁試射導彈傳遞了什麼信息？</h4><img alt="朝鮮突然頻繁試射導彈傳遞了什麼信息？" src="../../../../../../static01.nyt.com/images/2022/01/21/world/00nkorea-gameplan-01/00nkorea-gameplan-01-thumbLarge.html"></article></a></li><li><a href="#https://cn.nytimes.com/china/20220124/china-zero-covid-policy/zh-hant/?utm_source=top10-in-article&amp;utm_medium=articlepage&amp;utm_campaign=web"><article><h4>多地封鎖引發沮喪與抱怨，中國「清零」政策還能走多遠？</h4><img alt="多地封鎖引發沮喪與抱怨，中國「清零」政策還能走多遠？" src="../../../../../../static01.nyt.com/images/2022/01/20/world/00virus-china-lockdown-01/00virus-china-lockdown-01-thumbLarge.html"></article></a></li></ol></div></div></div></div></div><footer class="row copy-footer">&copy; 2022 The World Economy Observer.<ul class="footerLinkList"><li class="footerLink"><a rel="nofollow" href="/ad/">广告</a></li><li class="footerLink"><a rel="nofollow" href="/about-us/">关于我们</a></li><li class="footerLink"><a rel="nofollow" href="/contact/">联系我们</a></li><li class="footerLink"><a rel="nofollow" href="/tos/">服务条款</a></li><li class="purr-content"></li></ul></footer><script src="../../../../../../d1f1eryiqyjs0r.cloudfront.net/js/libs/require619b.js?v=f1810d8"></script><script src="../../../../../../d1f1eryiqyjs0r.cloudfront.net/js/web/article.min619b.js?v=f1810d8"></script></main></body>
<!-- Mirrored from cn.nytimes.com/business/20130722/c22drugs/zh-hant/dual/ by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 28 Jan 2022 14:16:48 GMT -->
</html>